# 2024-06-11--中药-马应龙-肛肠细分行业龙头，百年品牌守正创新_page18_表4公司收入拆分及盈利预测百万元

|   | 2022A | 2023A | 2024E | 2025E |
|---|------|------|------|------|
| 营业总收入 | 3,532.38 | 3,136.75 | 3,518.67 | 3,983.59 |
| YoY | -11.20% | 12.18% | 13.21% | 11.90% |
| 毛利率 | 42.41% | 41.91% | 43.73% | 44.01% |
| 医药工业 | 2,073.39 | 1,834.47 | 2,135.53 | 2,426.43 |
| YoY | -11.52% | 16.52% | 13.62% | 11.77% |
| 其中：治疗类 | 1,488.34 | 1,292.11 | 1,530.50 | 1,744.77 |
| yoy | -13.18% | 18.45% | 14.00% | 12.00% |
| 其他产品 | 585.05 | 542.36 | 605.03 | 681.66 |
| yoy | -7.30% | 11.55% | 12.67% | 11.18% |
| 医疗服务 | 258.67 | 344.76 | 465.43 | 605.06 |
| YoY | 33.28% | 35.00% | 30.00% | 25.00% |
| 医药流通 | 1,354.03 | 1,087.71 | 1,087.71 | 1,142.10 |
| YoY | -19.67% | 0.00% | 5.00% | 5.00% |
| 内部抵消 | (188.82) | (168.50) | (200.00) | (220.00) |
| 其他业务 | 35.12 | 38.30 | 30.00 | 30.00 |